Repare Therapeutics to Be Acquired by XenoTherapeutics
Repare Therapeutics (RPTX) announces acquisition by XenoTherapeutics for $1.82/share plus contingent value rights, expected to close Q1 2026.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Repare Therapeutics (RPTX) announces acquisition by XenoTherapeutics for $1.82/share plus contingent value rights, expected to close Q1 2026.
Barrick Mining explores splitting into separate North American and Africa-Asia entities.
FDA adds black box warning to Sarepta's (SRPT) Elevidys, limiting use to walking DMD patients after two deaths from liver failure. Stock rose 9% as investors relieved FDA maintained approval for walking patients rather than pulling drug completely.
Figure Technology Solutions (FIGR) shares jumped 18% to $40.65 after reporting Q3 earnings that crushed analyst expectations, with revenue up 55% and net income surging 227% year-over-year.
White House memo claims Alibaba provides tech support to Chinese military for operations targeting US infrastructure, raising national security concerns about data access and cyber threats.
Samsung raised memory chip prices by up to 60% due to the AI data center building race, leading to severe shortages and higher costs for tech products globally.